Cargando…
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Epithelial ovarian cancer is predominantly diagnosed at advanced stages which creates significant therapeutic challenges. As a result, the 5-year survival rate is low. Within ovarian cancer, significant tumor heterogeneity exists, and the tumor microenvironment is diverse. Tumor heterogeneity leads...
Autores principales: | Pereira, Madison, Matuszewska, Kathy, Jamieson, Colin, Petrik, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635771/ https://www.ncbi.nlm.nih.gov/pubmed/34867818 http://dx.doi.org/10.3389/fendo.2021.772349 |
Ejemplares similares
-
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
por: Matuszewska, Kathy, et al.
Publicado: (2021) -
Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022) -
Editorial: Hypoxia, oxidative stress, and endocrine cancers
por: Duvillié, Bertrand, et al.
Publicado: (2023) -
Liposomal delivery of gene therapy for ovarian cancer: a systematic review
por: Son, Jin Sung, et al.
Publicado: (2023) -
Hypoxia signaling pathway: A central mediator in endocrine tumors
por: Watts, Deepika, et al.
Publicado: (2023)